By Michele Maatouk
Date: Tuesday 16 Sep 2025
(Sharecast News) - Big pharmaceutical companies have ditched or paused nearly £2bn in planned UK investments so far this year, causing "suffering" to patients, as ministers gear up for discussions with Donald Trump amid a row over drug pricing. The government's plan for the life science sector, a key pillar of...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news